Immix Biopharma (IMMX) Treasury Shares (2022 - 2026)
Immix Biopharma (IMMX) reported Treasury Shares of $99963.0 for Q1 2026, little changed on a YoY basis from $99963.0 in Q1 2025, and little changed sequentially from $99963.0 in Q4 2025.
Immix Biopharma (IMMX) Treasury Shares (2022 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 5 years of Treasury Shares data on file, last reported at $99963.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $99963.0; the trailing twelve-month figure through Mar 2026 stood at $99963.0 (changed 0.0% YoY), and the FY2025 full-year result was $99963.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $99963.0 in Q1 2026, from $99963.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $72363.0 in Q4 2022 to a low of -$72363.0 in Q4 2023.
- A 5-year average of $4677.2 and a median of $37418.0 in 2022 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 78.62% in 2023, while the deepest fall reached 0.0% in 2023.
- Tracing IMMX's Treasury Shares over 5 years: stood at $99963.0 in 2022, then changed by 0.0% to $99963.0 in 2023, then changed by 0.0% to $99963.0 in 2024, then changed by 0.0% to $99963.0 in 2025, then changed by 0.0% to $99963.0 in 2026.
- Business Quant data shows IMMX's Treasury Shares at $99963.0 in Q1 2026, $99963.0 in Q4 2025, and $99963.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - | 99,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,363.00 |
| Mar 31, 2026 | 99,963.00 |
| Mar 31, 2026 | 72,363.00 |
| Mar 31, 2026 | 99,963.00 |
| Dec 31, 2025 | 99,963.00 |
| Dec 31, 2025 | 72,363.00 |
| Dec 31, 2025 | 72,363.00 |
| Dec 31, 2025 | 99,963.00 |
| Sep 30, 2025 | 72,363.00 |
| Sep 30, 2025 | 99,963.00 |
| Sep 30, 2025 | 99,963.00 |
| Sep 30, 2025 | 72,363.00 |
| Jun 30, 2025 | -72,363.00 |
| Jun 30, 2025 | -72,363.00 |
| Jun 30, 2025 | 99,963.00 |
| Jun 30, 2025 | 99,963.00 |
| Mar 31, 2025 | 99,963.00 |
| Mar 31, 2025 | 99,963.00 |
| Mar 31, 2025 | -72,363.00 |
| Mar 31, 2025 | -72,363.00 |